Scientists have developed a portable biosensor that can detect levels of BDNF, a protein linked to mental health conditions ...

A child’s early gut microbiome may influence their risk of developing depression, anxiety or other internalizing symptoms in ...

Alto Neuroscience, Inc. (“Alto”) (NYSE: ANRO), a clinical-stage biopharmaceutical company focused on the development of novel precision medicines for neuropsychiatric disorders, announced today that, ...

This collaboration sets out to explore whether using the Matter Neuroscience protocol combined with real-time neurofeedback can influence emotional brain networks relevant to depression. PALO ALTO, ...

Studies have linked excessive screen time to mental health problems like depression in adolescents. New research now suggests that this link may be driven by shorter sleep and worse organization of ...

Exercise reduces symptoms of depression and anxiety in children and adolescents reported a new study published in the Journal of the American Academy of Child & Adolescent Psychiatry. “Exercise is a ...

Separate brain processes cope with moment-to-moment versus big-picture experiences, which helps explain how parenting both ...

On Tuesday, Alto Neuroscience, Inc. (NASDAQ:ANRO) announced an asset purchase agreement with Chase Therapeutics Corporation for a portfolio of dopamine agonist drug combinations for ...

- Scientific Advisory Board brings together distinguished experts in neuroscience to support Denovo’s CNS development programs, including the Phase 3-ready lead program, biomarker-guided DB104 ...

The MarketWatch News Department was not involved in the creation of this content. -- Achieved Primary Endpoint with 30mg Dose of RE104 Demonstrating 23.0-Point Reduction from Baseline in ...